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INTRODUCTION
The olfactory nervous system consisting of an accessory and primary component is a highly regenerative region which naturally maintains neurogenesis and turnover of neurons throughout life [1] . Neurogenesis constantly occurs to replenish the olfactory system, with neurogenesis within the olfactory epithelium generating new sensory neurons while neurogenesis within the subventricular zone generates neuroblasts that colonise the olfactory bulb [2, 3] . For the primary olfactory sensory neurons, the successful regeneration and targeting is partially attributed to the presence of olfactory ensheathing glial cells (OECs) [4] [5] [6] [7] . We and others have previously shown that OECs are responsible for clearing large amounts of axonal debris generated from the continuous turnover of the olfactory nerve [7, J o u r n a l P r e -p r o o f cRPMI medium with CO 2 , the medium was incubated in 37 °C 5 % CO 2 for 30 min prior to the addition of J774a.1 cells. All cell lines used were between passages 7 and 15. The working dilutions for the primary antibodies were: rabbit-α-HTRA1 (1:50), rabbit-α-MIF (1:250), rabbit-α-CD74 (1:500), rabbit-α-CXCR2 (1:200), rabbit-α-CXCR4 (1:500), rat-α-PDGFRß1 (1:200), rabbit-α-fibronectin (Abcam) (1:500). Primary antibodies were detected with donkey-α-rabbit-Alexa488 (Abcam) at a concentration of 1:1000, goat-α-rat-Alexa647 (Abcam), and cells were stained with 20 µg/ml of Hoechst.
Immunolabelling of primary OECs and the mOEC cell line

Quantified fluorescence assays
Quantified fluorescence assays were performed to measure the expression levels of MIF and its potential binding partners in mOECs. The mOECs were seeded at 3000 cells/well in 384well plates. The primary antibodies were used to label MIF, HTRA1, CD74, CXCR2 and CXCR4 as described above. This time, the primary antibodies were detected with Alexa594conjugated donkey-anti-rabbit secondary antibodies. Following immunolabelling, cells were further labelled using CellMask TM 
RT-PCR
Polymerase chain reaction (PCR) for sequencing was performed using RNA obtained from immortalised mOECs. mOECs were cultured to confluence in a T75 filter flask and RNA was extracted from cells using TRIzol reagent (Invitrogen) as per manufacturer's instructions.
cDNA was synthesised from RNA using SuperScript III Reverse Transcriptase kit (Invitrogen). Design of oligonucleotide primers targeting the MIF RNA was performed using Primer3 (http://frodo.wi.mit.edu/). The primers were (F: 5' -3' sequence: CGGACCAGCTCATGACTTTTA, R: 5' -3' sequence: GGCAGCGTTCATGTCGTAAT), which had an included sequence size of 384 and an expected product size of 185 bp and were purchased from Sigma. GAPDH primers were: (F: 5' -3' sequence: AACTTTGGCATTGTGGAAGG, R: 5' -3' sequence: GGATGCAGGGATGATGTTCT);
GADPH was used as positive/loading control. Amplification was performed in a 25 µL reaction consisting of: 5 µL Colourless GoTaq Buffer (Promega), 2.0 µL 25 mM MgCl 2 (Promega), 0.5 µL 10 uM F primer, 0.5 µL 10 uM R primer, 0.5 µL 10 mM dNTPs (Bioline), 
Confrontation assays
Confrontation assays were performed to investigate the role of MIF in interactions between the mOEC and J774a.1 (macrophage/monocyte) cell lines. mOECs and J774a.1 cells were seeded at a cell density of 6000 cells/chamber using their respective cell-culture media into the two confronting chambers in a culture-insert 2 well in µ-Dish (Ibidi). The plates were incubated at 37 °C 5 % CO 2 for 24 h to allow for cell adherence. Following this adherence period, the medium was removed from each chamber and the chamber walls separating the cell types were removed. The confrontation wells, now without chambers, were filled with a 1:1 combination of mOEC cell-line medium and cRPMI medium. The same configuration was used for mOEC-mOEC and J774a.1-J774a.1 confrontation assays. The confrontation assay was also used to test the effect of ISO-1 on cell-cell interactions between mOECs and J774a.1 cells. The confrontation assay was performed with the addition of 25 µM of ISO-1 as per manufacturer's recorded IC50 value (Abcam). The confrontation plate was imaged daily for three days in DIC using the Olympus IX-73 microscope (4x and 20x objectives) along the convergent borders of the two cell types. On day three, the plate was fixed by addition of 2.5% PFA in 1 % TritonX (Sigma-Aldrich) (final concentration of 0.25 % PFA) for 24 h at 4 °C. Analysis of the gap closure was performed using Image J-macro MRI_Wound_Healing_Tool and cross-checked with manual measurement of the gap size.
Performed in triplicate, four fields of view analysed at each timepoint.
Phagocytosis assay
A phagocytosis assay was performed to investigate the role of MIF protein on the phagocytosis of axonal debris by mOECs. ZsGreen fluorescent axonal debris was obtained by dissociation of olfactory nerve fascicles dissected from OMP-ZsGreen mice [61] . mOECs were seeded into 384-well plate (#781090, Greiner Bio-One) at a confluency of 4000 mOECs/well. The plate was left at room temp on a solid surface for 30 min to allow cell Journal Pre-proof J o u r n a l P r e -p r o o f adherence, after which the plates were incubated for 24 hours at 37 °C, 5 % CO 2 . The medium was then removed with light suction and replaced with 50 µL fresh medium per well containing axonal debris at a density of 5 ng/mL and MIF at 5 ng/mL, 10 ng/mL, 50 ng/mL and 100 ng/mL and a control without any added MIF. Additional wells were also prepared as a blank without any added debris to standardise for background fluorescence during analysis.
The plates were left for an additional 24 h after which the cells were fixed with addition of 5 
Cell Count assay
A cell count assay was performed to determine whether MIF affects the proliferation of cell line mOECs. mOECs were seeded at a density of 3000 cells/well into a 384-well plate (#781090, Greiner Bio-One). The plate was left for 30 minutes to allow cell adherence, after which the plates were incubated for 24 hours. The medium was then removed with light suction and replaced with 50 µL fresh medium containing MIF at a concentration of 5 ng/mL, J o u r n a l P r e -p r o o f 10 ng/mL, 50 ng/mL and 100 ng/mL and a control without any added MIF. Additionally, another series of wells were tested with mOECs treated with both MIF and axonal debris at a density of 5 ng/mL. Cells were fixed and stained at 24 h post treatment using the addition of 5.5 µL of a solution of 2.5 % Paraformaldehyde, 1 % Triton X-100 (Sigma-Aldrich) and 20 µg/mL of Hoechst (nuclear stain) at 4 °C. Cells were imaged using Operetta High-Content Imaging System (Perkin Elmer), and nuclei were then quantified using the Harmony software v3.5 (Perkin Elmer).
A cell count assay was performed to investigate the role of MIF protein on the viability of mOECs and a J774a.1 cell line. mOECs were seeded into 384-well plate (#781090, Greiner Bio-One) at a confluency of 4000 mOECs/well. Similarly, for J774a.1 macrophage/monocytes cells were seeded at a density of 8000 cells/well. The plate was left at room temp on a solid surface for 30 min to allow cell adherence, after which the plates were incubated for 24 hours at 37 °C, 5 % CO 2 . The medium was then removed with light suction and replaced with 50 µL fresh medium per well containing MIF at 5 ng/mL, 10 ng/mL, 50 ng/mL and 100 ng/mL and a control without any added MIF. Cells were left for 45 hours to incubate after which Hoechst was added to each well at 20 µg/mL. Following a final 3 hours, cells were imaged using the Operetta high-content imaging system and Harmony v3.5 software was used to define viable cells based on Hoechst labelling. Counts were performed in biological duplicate and technical triplicate.
Image capture
Tissue sections and primary cell populations were imaged using an Olympus FV1000 spectral microscope. For quantified fluorescence assays, mOECs immunolabelled with antibodies against MIF and its binding partners were imaged using Perkin Elmer Operetta and a 20x objective. Cells in confrontation assay plates were imaged daily using Olympus IX-73 at 4x J o u r n a l P r e -p r o o f and a 20x objective and using the Olympus FV1000 spectral microscope following fixation and immunolabelling at the end-point of the assays.
Image analysis
Images of immunolabelled tissue sections were analysed using Olympus Fluoroview version 4.2b and the open-software Fiji -ImageJ version 1.51n. In vitro images were analysed using Harmony version 3.5 and Fiji. In vivo imaging was performed using an Olympus FV1000 spectral confocal microscope.
RESULTS
OECs in the olfactory nerve express the MIF and HTRA1 proteins
MIF is expressed in peripheral nerves [56] , but its expression in the olfactory nerve has not been characterised. Some types of glial cells (astrocytes [54] and Schwann cells [57, 58] ) have previously been shown to express MIF. To date, it is not known whether OECs, the glia of the primary olfactory nervous system express MIF. We therefore investigated whether MIF was expressed in the primary olfactory nervous system, in particular by OECs. In astrocytes, MIF has been shown to bind and regulate the activity of the serine protease HTRA1 [37] . We therefore also characterised the expression of HTRA1 in the olfactory nerve and OECs. We immunolabelled tissue sections from the primary olfactory nervous system of wild-type and S100β-DsRed transgenic mice. In the S100β-DsRed mice, OECs are easily visualised by expression of DsRed; we and others have previously demonstrated that the DsRed-expressing OECs express the key OEC marker p75 NTR in vivo and in vitro [7, 59, 60, 62] . We found that both the MIF and the HTRA1 proteins were present within the olfactory nerve ( Fig. 1 ). MIF expression did not co-localise with olfactory marker protein (OMP)-expressing primary olfactory axons, as shown in cross-sections of olfactory nerve bundles immediately beneath the olfactory mucosa (wild-type mice; Fig. 1 We also found that surrounding cells, most likely fibroblasts, expressed MIF; this is not surprising since MIF has been shown to be expressed in and secreted by fibroblasts [64] . Expression of HTRA1 also co-localised with DsRed-positive OECs (Fig. 1L-N) .
MIF and HTRA1 are expressed in OECs in the accessory olfactory nerve
We also examined the accessory olfactory nervous system, which mediates pheromone detection, for MIF/HTRA1 expression. Accessory olfactory neurons extend from the vomeronasal organ (located near the vomer bones in the nasal cavity) to the accessory olfactory bulb which is found dorsally to the main olfactory bulb; accessory axon fascicles project along the septum and between the main olfactory bulbs ( Fig. 2a ). In the olfactory mucosa, the accessory olfactory nerve fascicles can be easily distinguished from main olfactory nerve fascicles as they lie deeper compared to the main olfactory axon fascicles. In addition, accessory olfactory axons have weak expression of OMP, while the main olfactory axons strongly express OMP ( Fig. 2B-C) [13, 61] . In the accessory olfactory nerves, MIF was expressed by the cell bodies and processes of the OECs ( 
Cultured primary OECs express MIF and HTRA1
To verify that OECs expressed MIF and HTRA1, primary OECs were cultured from s100β-DsRed mice and immunocytochemistry for MIF and HTRA1 was performed. Primary OEC cultures contain both OECs and contaminating olfactory fibroblasts, however, only OECs express the DsRed fluorescent protein (Fig. 3A , D, F, H) [59] . In addition to DsRed fluorescence, we also used immunolabelling for P75NTR to verify OEC identity [59, 62] ( Fig. 3G-H) . To label fibroblasts, we immunolabelled cells for the fibroblast markers plateletderived growth factor receptor β (PDGRFβ) [66, 67] (Fig. 3I , K) and fibronectin [68] (Fig. 3 B, J, K). As previously shown by others [69] , we found that the fibronectin antibody labelled 
HTRA1 and MIF are expressed in a mouse OEC cell line and MIF is secreted by OECs
To support the immunolabelling data from primary mouse OECs, immunolabelling for MIF and its potential binding partners followed by quantified fluorescence assays were performed in a mouse OEC cell line (mOECs) [60] . This cell line consists of only OECs and no fibroblasts. OECs were immunolabelled using antibodies against MIF and its binding partners HTRA1, CD74, CXCR2 and CXCR4. Similar to the primary cell immunolabelling, both MIF and HTRA1 were expressed in the mOEC cell line, however, the other potential MIF binding partners, CD74, CXCR2 and CXCR4, were not expressed ( Fig. 4A, B ). We also confirmed the expression of MIF in the mouse OEC cell line using RT-PCR and primers specific for MIF. The amplicon consisted of the central exon with the expected product size of 185 bp.
The product of the RT-PCR was consistent with this expected product (Fig. 4C ). Following this we used a sandwich ELISA to quantify the concentration of MIF in the supernatant collected from a confluent T75 flask of mOECs cultured over 16 hours. 5221.87 pg/mL of MIF was detected in the collected supernatant ( Fig. 4D-E) . These results provide further evidence that MIF is expressed by OECs.
MIF mediates separation between mOECs and J774a.1 macrophages/monocytes
We have previously shown that macrophages are largely absent from olfactory nerve fascicles [7] . Since we found that OECs express MIF, and because MIF can inhibit migration of monocytes/macrophages [16] [17] [18] [19] [20] , we determined whether MIF regulated the interaction between mOECs and J774a.1 cells. We first determined whether mOECs and J774a.1 cells intermingled or repelled each other in a confrontation assay. The two cell types were cultured J o u r n a l P r e -p r o o f in two-well chambers separated by a removable wall. Following removal of the wall, the two cell populations migrated towards each other but showed very little intermingling after 24 and 48 h ( Fig. 5A, B, D) . We next tested whether a MIF inhibitor, ISO-1, which blocks the tautomerase activity of MIF, affected the separation between mOECs and J774a.1 cells.
When ISO-1 was added to confrontation plate, the space between the two cell types was significantly smaller than in the absence of ISO-1 and the cell types quickly intermingled ( Fig. 5C, E) . Furthermore, when ISO-1 was added, occasionally, populations of the J774a.1 cells would float between the seeding zones due to their low adherent monocyte properties, and subsequently adhere within the OEC region (Fig. 5E, arrows) . This occurrence was never seen in the absence of ISO-1.
We next determined how mOECs alone or and J774a.1 cells alone behaved when first cultured in two chambers and then allowed to migrate freely (i.e., mOEC-mOEC or J774a.1-J774a.1 confrontation assays). When mOECs were plated in each chamber, the two populations rapidly intermingled over a 48 h time-period (Fig. 5F ). When pure populations of J774a.1 cells (which also in themselves express MIF [71] ) were plated in both chambers, the cells behaved similarly to what we observed with mOEC-J774a.1 confrontation assaysthe gap between the two cell populations decreased at a similar rate and the two populations showed little intermingling after a 48 h period (Fig. 5G) . These data suggest that MIF inhibits migration/cell intermingling by acting on macrophages, not OECs.
MIF at low concentration stimulates phagocytosis of axonal debris by mOECs, and increases the number of J774a.1 cells but not mOECs
Finally, as OECs are potent phagocytes and MIF has been shown to increase phagocytosis in macrophages in an autocrine manner [72] , we examined whether addition of exogenous MIF regulates OEC phagocytosis. In vivo, OECs phagocytose axonal debris arising from the turnover of primary olfactory neurons and their axons. We therefore prepared cell debris of (Fig. 6) , with a five times increase in phagocytosis with 5 ng/mL, and an 18 times increase in phagocytosis at 50 ng/mL.
J o u r n a l P r e -p r o o f
Since it is possible that the increased mingling of OECs and J774a.1 cells that we observed upon inhibition of MIF (confrontation assays) could also partially have been due to effects on cell proliferation/viability, we also determined whether MIF affected the numbers of mOECs and J774a.1 cells. No significant changes in cell counts occurred when OECs were treated with MIF, however, the number of J774a.1 cells was increased by 44 % following 48 hours incubation with MIF at 5 ng/mL; this increased to 57 % at 10 ng/mL. Only at a high concentration (100 ng/mL), did MIF caused a 35 % decrease in cell count.
Discussion
We here demonstrate that macrophage migration inhibitory factor (MIF) is expressed in the primary olfactory nervous system. In tissue sections from young (p10) mice, we demonstrated that the MIF protein is expressed by olfactory ensheathing glial cells (OECs) and surrounding olfactory fibroblasts in both the main and accessory olfactory nerves. We showed a similar pattern of expression for the MIF binding partner HTRA1 and confirmed that these cells continued to express MIF and HTRA1 after isolation and in vitro culture. We also showed that a mouse OEC cell line (devoid of fibroblasts) expressed MIF and HTRA1, but not detectable levels of the MIF receptors CD74, CXCR2 and CXCR4. Whilst expression of MIF was high in olfactory glia and fibroblasts, we did not detect expression of MIF in axons from olfactory neurons. MIF has been shown to be expressed in cortical and hippocampal brain neurons [54, 73, 74] and peripheral neurons [75, 76] , its expression is very low in motor neurons [30, 31] ; thus, it is possible that MIF expression varies greatly between types of neurons.
MIF has previously been shown to be expressed in the brain [44, 46, 73, 77, 78] , spinal cord [75, 76, 79] , peripheral ganglia [76] and peripheral nerves [56, 80, 81] . Thus, it is consistent that MIF is expressed in the olfactory nerve. It is interesting that OECs found in nerves of both the primary and accessory olfactory nervous systems expressed MIF and HTRA1 as both systems play slightly different roles, with the main primary olfactory system responsible for general olfaction, and the accessory olfactory system largely associated with pheromones [82] . The similarities between these systems may elude to the role of MIF within the primary and accessory olfactory systems, one hypothesis is a potential role in neuronal turnover within the region. It is possible that MIF has specific roles in the olfactory nerve due to the unique continuous turnover of neurons. In rodents, olfactory neurons live for approximately Journal Pre-proof J o u r n a l P r e -p r o o f one month, and 1-3 % of neurons are turned over daily [1] . The evolutionary reason for this turnover is most likely that olfactory neurons are frequently subjected to mechanical and environmental damage. Dendrites of primary olfactory sensory neurons extend directly into the olfactory epithelium and the neurons die when the epithelium is damaged [14, 83, 84] .
While our data suggests that MIF contributes to regulating macrophage-OEC interactions, in vivo confirmation of the hypothesis is needed to fully understand the role of MIF within the context of the complex in vivo environment. One strategy to investigate the role of MIF in vivo would be to induce the death of olfactory sensory neurons using methyl bromide inhalation [85] , zinc sulphate [86] or methimazole [7, 14] combined with selective inhibition of MIF; selective inhibition of the OEC-macrophage MIF response would be necessary as MIF has numerous roles of various cell types.
The anatomy of the olfactory nerve also leads to olfactory neurons being frequently exposed to microorganisms. Whilst a number of immune mechanisms in the nasal mucosa protect against infections, epithelial injuries are reasonably frequent and the olfactory nerve is thus regularly exposed to bacteria and viruses (reviewed in [4, 87, 88] ). Thus, it is possible that MIF is also involved in innate immune responses to microorganisms, as is the case in CNS microglia [89] . In our previous studies, we found that the olfactory nerve fascicles were almost completely lacking macrophages, and macrophages were never observed to be in direct contact with axons from primary olfactory neurons [7] . Even after large-scale injury to the olfactory nerve [14] and during infection with one of the few bacteria capable of infecting the CNS via the olfactory nerve, Burkholderia pseudomallei [15] , macrophage infiltration of the olfactory nerve was very limited. Instead, we found that the OECs constitute the main innate immune cells in the olfactory nerve, responsible for phagocytosing and degrading both axonal debris and bacteria [7, 9] . As we have here demonstrated that MIF is expressed in OECs, it is possible that MIF is also involved in OEC-mediated responses to pathogens.
The mechanisms behind the exclusion of macrophages from olfactory nerve fascicles remain unknown. Since MIF can inhibit random migration of macrophages [16] [17] [18] [19] [20] , we investigated whether MIF had any effect on the intermingling of OECs and macrophages (cell lines) in vitro. We found that the two cell populations did not intermingle except for when MIF was inhibited, suggesting that MIF has a key role in separating the two cell types. As we wanted to keep conditions as physiological as possible, we did not inhibit cell proliferation.
Therefore, we cannot rule out that the decrease in space between the two cell populations could also be due to effects on proliferation in addition to migration. As MIF did not have The data from our experiments examining the gap closure between segregated OEC-OEC and macrophage-macrophage populations may suggest that MIF acts on macrophages rather than OECs. We found that the macrophage-macrophage populations behaved similarly to the OEC-macrophage populations (slow gap closure, little intermingling), but that the OEC-OEC populations freely intermingled. In fact, the OEC-OEC populations behaved in a similar manner to the OEC-macrophage populations in the presence of ISO-1. Thus, we suggest that in the primary olfactory nervous system, MIF, secreted by both OECs and macrophages, may act to inhibit migration of macrophages into olfactory nerve fascicles surrounded by OECs. It is important to note here that the action of MIF may not necessarily be to inhibit migration of macrophages into a tissue, but instead to inhibit random macrophage migration. This may lead to macrophage recruitment, as has been suggested to occur in peripheral nerves after injury [56, 80, 81] . Our data, however, suggests that in the healthy olfactory nervous system, MIF mediates segregation between OECs and macrophages rather than macrophage recruitment. Future experiments could address the in vivo mechanisms and roles of MIF in regulating macrophage interactions within the olfactory system. For example, an injury model such as intranasal methimazole [7, 14] or zinc sulphate administration [86] or methyl bromide inhalation [85] results the widespread death of olfactory neurons and could be used to examine the response following injury in vivo.
In addition to the proposed role of MIF inhibiting macrophage invasion into olfactory nerves, we found that MIF strongly stimulates the phagocytosis of axonal debris by OECs. In macrophages, MIF can play a role in the phagocytic pathways by enhancing Toll-like receptor-4 (TLR4) expression in an autocrine or paracrine manner [22, 72] . This in turn forms a complex with Lymphocyte antigen 96 (LY96) and CD14 and mediates signal transduction involved in LPS activated pathways [90] ; subsequently the impairment of MIF results in impaired defence against gram-negative bacteria [91] . However, MIF's role in glial cell J o u r n a l P r e -p r o o f phagocytosis has not been extensively studied. In microglia and astrocytes, glial cell types which are both important components of the immunological function of the CNS, MIF is shown to inhibit the pro-inflammatory M1 activation in microglia cells via the CD74 receptor [92] . Conversely, via the same receptor MIF stimulates activation of astrocytes [93] .
However, our results here demonstrate a lack of CD74 expression in OECs which thus may use a phagocytic pathway similar to macrophages described above.
Furthermore, this lack of CD74 expression is a potentially interesting difference between OECs and Schwann cells (which have been shown previously to express CD74 [94, 95] ).
Additionally, this lack of CD74 expression may explain differences between OEC response to MIF demonstrated here and Schwann cell response to MIF in the literature; MIF administration exhibited no proliferative effect on OECs whereas on Schwann cells administration of as little as 0.25 µg/mL of recombinant MIF stimulated proliferation via CD74 activation of the ERK and JNK pathways [95] . Similarly, J774a.1 macrophage/monocyes also express this receptor, and so the increase in cell number seen when MIF was added at 5 and 10 ng/mL to J774a.1 likely acts via this pathway [28, 96] . The difference in CD74 expression between OECs and Schwann cells may, however, be the result of a lack of injury stimulus with the OEC population examined here, as Schwann cell expression of CD74 is seen post axotomy in vivo [95] . Furthermore, CD74 gene expression has been seen previously expressed by OECs following their transplantation into a rat SCI model [97] . The potential expression changes of CD74 in OECs following olfactory nerve injury then may be an interesting focus for further study.
ISO-1, the MIF inhibitor used in this study, binds to a catalytic site in MIF responsible for its tautomerase enzyme activity [98] . The physiological roles of this MIF activity remain largely unknown [99] , but without tautomerase function, the cytokine functions of MIF are attenuated (however, not completely lacking) [100, 101] . Whilst MIF can indeed promote neurogenesis and act as a neurotrophin [46] [47] [48] , inhibition of MIF with ISO-1 has been shown to reduce inflammatory damage in some animal models of Alzheimer's disease [102] and spinal cord injury [103] , as well as protecting against microglia-mediated inflammation in sepsis [98] . Thus, the tautomerase activity of MIF is most likely crucial for many of its functions including regulation of macrophage behaviours [101] .
We found that mOECs did not express CXCR4 at a level quantifiable in our immunofluorescence assay. Primary OECs and olfactory fibroblasts have previously been J o u r n a l P r e -p r o o f shown to express CXCR4 [104, 105] , and to up-regulate expression of this receptor following oxygen deprivation, which in turn promoted neurite outgrowth in hypoxic conditions [104, 105] . Thus, it is likely that OECs do have the capacity to express or up-regulate this receptor in certain stress responses, which may also reflect roles of MIF in such situations. Expression of the other MIF receptors in OECs has not been previously described. The fact that mOECs expressed no or very low levels of CD74 in our assay was somewhat surprising, since Schwann cells in peripheral nerves, which share many morphological, molecular and functional properties with OECs (reviewed by [4] ), are thought to express high levels of CD74 [94] . The expression of CXCR2 in Schwann cells has not been described, but CXCR2 is expressed in central nervous system glia, in particular oligodendrocytes [106] . As we suggest that MIF mediates OEC-macrophage segregation by acting on macrophages only, it is possible that OECs do not have the receptor required for this MIF-mediated function.
Perhaps the effects on cell migration/intermingling are mediated by any of the MIF receptors expressed by macrophages but not OECs (CD74, CXCRs).
The serine protease HTRA1, a 51 kDa highly conserved protein [107, 108] is expressed in many tissues including the brain [38, 39] was recently demonstrated to be a binding partner of MIF [37] . HTRA1 is secreted from cells and cleaves certain growth factors and components of the extracellular matrix [107] [108] [109] [110] [111] [112] [113] [114] [115] , such as fibroblast growth factor-8 (FGF-8) [116] . HTRA1 also has important intracellular roles in cell migration and proliferation, as well as in tumour suppression [42, 43, 117, 118] . MIF was recently identified as the first endogenous inhibitor of HTRA1, blocking HTRA1 protease activity. This activity in turn modulated the migration of astrocytes; FGF-8 stimulates astrocyte migration, an effect that is inhibited by HTRA1. MIF inhibited HTRA1-mediated degradation of FGF-8, thus stimulating migration of astrocytes [37] . To date, it is unknown whether OECs can be modulated by FGF-8 or the structurally similar FGF-17/FGF-18; however, HTRA1 may have many other substrates with potential to influence OECs. Thus, interactions between MIF and HTRA1 may be important for regulating growth-factor mediated effects on glia.
Interestingly, HTRA1 has been implicated to have a role in similar diseases as MIF, in particular cancer and neurodegeneration [41] [42] [43] . In most of these diseases, MIF is suggested to be associated with disease worsening and progression, whilst HTRA1 is protective [42, 117] . For example, in Alzheimer's disease, which is characterised by elevated MIF levels, HTRA1 has been shown to degrade Tau and amyloidβ aggregates [119] , Thus, in In summary, we have demonstrated the expression of MIF and HTRA1 in murine OECs and olfactory fibroblasts in vivo and in vitro, as well as in an OEC cell line. We also showed that MIF is quantifiably secreted from OECs and that it appeared to mediate segregation between OECs and macrophages, in alignment with the fact that macrophages are largely absent from olfactory nerve fascicles in vivo. 
